Semaglutide 20mg
Semaglutide is a synthetic 31-residue analogue of glucagon-like peptide-1 with a C18 fatty diacid side chain that binds albumin and extends its half-life to about a week. It is the most studied of the GLP-1 receptor agonists, with a clinical record running to tens of thousands of trial participants. Supplied for laboratory research use only. Not for human or veterinary use.
A long-acting GLP-1 receptor agonist.
Semaglutide is a synthetic 31-residue analogue of glucagon-like peptide-1 with a C18 fatty diacid side chain that binds albumin and extends its half-life to about a week. It is the most studied of the GLP-1 receptor agonists, with a clinical record running to tens of thousands of trial participants.
What the research shows
Studies have documented effects on glucose-dependent insulin secretion, glucagon suppression, gastric emptying and appetite, along with body-weight regulation.
The SUSTAIN, STEP and SELECT programmes provide extensive efficacy, safety and cardiovascular-outcome data, and well-characterised pharmacokinetics.
Why researchers choose Aevryn Labs
Every batch is tested at a leading Australian university, where HPLC and mass spectrometry confirm a purity of 99% or higher. No generic overseas certificates.
Explore the research library
